Is there a protein target that is really untreatable? It's not that these targets can't be treated with medication, but they pose a challenge. “It's a problem that artificial intelligence (AI) can solve in a unique way,” Michelle Chen, PhD, chief business officer at Insilico Medicine, told GEN. At AACR 2024, Insilico Medicine will present the latest results of its work with AI in the discovery and development of cancer drugs. The company, which is in the clinical phase of generative AI-driven drug development, will present five preclinical programs in poster presentations.